Analyst Consensus ?
ConsensusHold44 ratings
Bullish1738.6%
Neutral2352.3%
Bearish49.1%
1 unmapped firm rating excluded from the percentages.
Essex Property Trust, Inc. · ESS · FY2026 Q1 · Calendar Q2 2026
Essex Property Trust Beats Q1 FFO as Occupancy Gains and Buybacks Offset Redemption Headwinds
Essex Property Trust delivered a solid Q1 2026, with core FFO per share of $1.65 exceeding the midpoint of guidance on higher same-property revenue and flat operating expenses. A 20-bp YoY occupancy gain and strong rent growth in Northern California underscore the benefits of operating in supply-constrained West Coast markets. Early structured-finance redemptions pulled forward $90 million from 2027/28, creating a near-term FFO headwind, but management offset this with a $62 million share repurchase at $243.76 per share (6.5% implied FFO yield), keeping full-year guidance unchanged. With cap rates in the mid-4% range offering a discount to private market valuations, Essex has deployed $1.7 billion as the largest buyer of West Coast multifamily assets over the past two years. The stock initially dipped 1.1% on the print but drifted 4.3% higher over subsequent sessions, suggesting the…
Reported After market closeNYSEReal Estate
$18.11B market cap
100quality score
Company context
Snapshot as of publicationEssex Property Trust, Inc., a prominent S&P 500 constituent, operates as a vertically integrated real estate investment trust (REIT). The company focuses on the purchase, construction, renovation, and ongoing management of residential apartment complexes across select West Coast regions. Currently, Essex maintains ownership interests in 246 apartment communities, offering a total of roughly 60,000 homes, with an additional six properties actively advancing through various stages of development.
Earnings scorecard
Reported versus consensus
Reported EPS
$1.65
Consensus $1
EPS surprise
+16.2%
Reported versus consensus
Reported revenue
$482.4M
Consensus $479.9M
Revenue surprise
+0.5%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$281.86Previous close
$250Low
$304.16Average
$375High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 30, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 22, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 21, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 14, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Jul 9, 2026 |
| Raymond James | Outperform | Market Perform | Upgrade | Jun 26, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 25, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jun 10, 2026 |
| Truist Securities | Hold | Hold | Maintain | May 27, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | May 18, 2026 |
| UBS | Neutral | Neutral | Maintain | May 14, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | May 4, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Apr 30, 2026 |
| Stifel | Hold | Hold | Maintain | Apr 29, 2026 |
| Baird | Neutral | Neutral | Maintain | Mar 2, 2026 |
| BMO Capital | Market Perform | Outperform | Downgrade | Jan 9, 2026 |
| Jefferies | Hold | Buy | Downgrade | Dec 16, 2025 |
| JMP Securities | Market Perform | Market Perform | Maintain | Feb 6, 2025 |
| Deutsche Bank | Buy | Hold | Upgrade | Jan 21, 2025 |
| B of A Securities | Neutral | Buy | Downgrade | Sep 24, 2024 |
| Wedbush | Neutral | Neutral | Maintain | Aug 5, 2024 |
| Citigroup | Neutral | Buy | Downgrade | Sep 8, 2023 |
| Wolfe Research | Underperform | Peer Perform | Downgrade | May 15, 2023 |
| Keybanc | Overweight | Downgrade | Dec 14, 2022 | |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Dec 14, 2022 |
| Goldman Sachs | Buy | Buy | Maintain | Nov 14, 2022 |
| Credit Suisse | Underperform | Underperform | Maintain | Jun 23, 2022 |
| BTIG | Neutral | Buy | Downgrade | May 19, 2021 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | May 27, 2020 |
| BTIG Research | Neutral | Buy | Downgrade | Nov 25, 2019 |
| Sandler O'Neill | Buy | Hold | Upgrade | Nov 18, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jul 26, 2019 |
| Janney Capital | Buy | Neutral | Upgrade | Dec 20, 2018 |
| Capital One Financial | Equal Weight | Equal Weight | Maintain | Oct 22, 2018 |
| Bank of America | Buy | Buy | Maintain | Jun 8, 2018 |
| Capital One | Overweight | Equal Weight | Upgrade | May 16, 2016 |
| Zelman | Sell | Hold | Downgrade | Jan 27, 2016 |
| Cowen & Co. | Perform | Market Perform | Maintain | Jan 12, 2016 |
| BB&T Capital | Buy | Buy | Maintain | Nov 10, 2015 |
| Canaccord Genuity | Hold | Hold | Maintain | Nov 3, 2015 |
| DA Davidson | Neutral | Neutral | Maintain | Apr 8, 2015 |
| McNicoll Lewis Vlak | Hold | Hold | Maintain | Dec 20, 2013 |
| Compass Point | Neutral | Neutral | Maintain | Nov 5, 2013 |
| ISI Group | Buy | Neutral | Upgrade | Oct 7, 2013 |
| Imperial Capital | Outperform | Outperform | Maintain | Feb 4, 2013 |
Named analyst price targets
Upside is calculated against the persisted previous close $281.86. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Evercore ISI | Analyst unavailable | $303 | $284.39 | +7.5% | Jul 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $292.75 | $296.8 | +3.9% | Jul 30, 2026 |
| Wells Fargo | James Feldman | $297 | $294.01 | +5.4% | Jul 22, 2026 |
| Piper Sandler | Analyst unavailable | $352 | $293.83 | +24.9% | Jul 21, 2026 |
| Deutsche Bank | Analyst unavailable | $330 | $293.83 | +17.1% | Jul 20, 2026 |
| Barclays | Richard Hightower | $296 | $297.48 | +5.0% | Jul 14, 2026 |
| Scotiabank | Analyst unavailable | $307 | $293.76 | +8.9% | Jul 9, 2026 |
| Raymond James | Buck Horne | $320 | $285.57 | +13.5% | Jun 26, 2026 |
| Morgan Stanley | Analyst unavailable | $302 | $283.42 | +7.1% | Jun 25, 2026 |
| UBS | Analyst unavailable | $290 | $276.91 | +2.9% | Jun 18, 2026 |
| Mizuho Securities | Analyst unavailable | $308 | $284.78 | +9.3% | Jun 10, 2026 |
| Evercore ISI | Analyst unavailable | $296 | $285.42 | +5.0% | Jun 8, 2026 |
| Evercore ISI | Steve Sakwa | $295 | $272.64 | +4.7% | Jun 1, 2026 |
| Truist Financial | Analyst unavailable | $286 | $278.81 | +1.5% | May 27, 2026 |
| Morgan Stanley | Analyst unavailable | $293 | $266.83 | +4.0% | May 15, 2026 |
| Scotiabank | Analyst unavailable | $282 | $269.75 | +0.0% | May 14, 2026 |
| UBS | Michael Goldsmith | $278 | $269.94 | -1.4% | May 14, 2026 |
| Barclays | Analyst unavailable | $277 | $263.55 | -1.7% | May 11, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $291 | $263.35 | +3.2% | May 4, 2026 |
| Piper Sandler | Analyst unavailable | $310 | $263.35 | +10.0% | May 4, 2026 |
| RBC Capital | Brad Heffern | $288 | $262.58 | +2.2% | Apr 30, 2026 |
| Barclays | Richard Hightower | $272 | $255.37 | -3.5% | Apr 27, 2026 |
| Stifel Nicolaus | Analyst unavailable | $278 | $250.96 | -1.4% | Feb 5, 2026 |
| Barclays | Analyst unavailable | $292 | $249.14 | +3.6% | Jan 13, 2026 |
| BMO Capital | John Kim | $280 | $256.95 | -0.7% | Jan 9, 2026 |
| UBS | Michael Goldsmith | $274 | $251.06 | -2.8% | Jan 8, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $290 | $256.89 | +2.9% | Jan 5, 2026 |
| Truist Financial | Michael Lewis | $273 | $254.66 | -3.1% | Dec 16, 2025 |
| Jefferies | Linda Tsai | $282 | $259.34 | +0.0% | Dec 15, 2025 |
| Barclays | Richard Hightower | $290 | $260.25 | +2.9% | Nov 25, 2025 |
| Mizuho Securities | Analyst unavailable | $284 | $261.2 | +0.8% | Nov 24, 2025 |
| Evercore ISI | Steve Sakwa | $271 | $247.64 | -3.9% | Nov 3, 2025 |
| Evercore ISI | Analyst unavailable | $279 | $255.86 | -1.0% | Oct 13, 2025 |
| Wells Fargo | James Feldman | $280 | $255.86 | -0.7% | Oct 13, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $300 | $267.66 | +6.4% | Oct 1, 2025 |
| Barclays | Richard Hightower | $297 | $266.22 | +5.4% | Sep 30, 2025 |
| Truist Financial | Michael Lewis | $283 | $251.68 | +0.4% | Aug 12, 2025 |
| Scotiabank | Analyst unavailable | $309 | $257.36 | +9.6% | Aug 5, 2025 |
| Scotiabank | Nicholas Yulico | $320 | $284.46 | +13.5% | Jun 13, 2025 |
| RBC Capital | Brad Heffern | $309 | $284.47 | +9.6% | May 1, 2025 |
| BMO Capital | John Kim | $310 | $270.06 | +10.0% | Jan 13, 2025 |
| RBC Capital | Brad Heffern | $302 | $270.06 | +7.1% | Jan 9, 2025 |
| Bank of America Securities | Joshua Dennerlein | $321 | $309.65 | +13.9% | Sep 24, 2024 |
| Goldman Sachs | Julien Blouin | $318 | $302.69 | +12.8% | Sep 4, 2024 |
| Truist Financial | Mike Lewis | $294 | $294.62 | +4.3% | Aug 26, 2024 |
| Piper Sandler | Alexander Goldfarb | $355 | $296.09 | +25.9% | Aug 26, 2024 |
| Piper Sandler | Alexander Goldfarb | $315 | $273.38 | +11.8% | Jun 28, 2024 |
| Scotiabank | Nicholas Yulico | $285 | $277.2 | +1.1% | Jun 14, 2024 |
| Mizuho Securities | Robert Stevenson | $266 | $252.91 | -5.6% | May 30, 2024 |
| Robert W. Baird | Amanda Sweitzer | $264 | $259.4 | -6.3% | May 28, 2024 |
| Morgan Stanley | Adam Kramer | $250 | $260.56 | -11.3% | May 14, 2024 |
| Truist Financial | Michael Lewis | $255 | $243.5 | -9.5% | Apr 9, 2024 |
| Truist Financial | Mike Lewis | $259 | $241.41 | -8.1% | Mar 28, 2024 |
| Raymond James | Buck Horne | $265 | $237.6 | -6.0% | Mar 18, 2024 |
| Mizuho Securities | Robert Stevenson | $250 | $232.66 | -11.3% | Feb 28, 2024 |
| Stifel Nicolaus | Simon Yarmak | $250 | $239.05 | -11.3% | Jul 18, 2023 |
| Scotiabank | Nicholas Yulico | $240 | $212.27 | -14.9% | Apr 18, 2023 |
| Wells Fargo | James Feldman | $208 | $204.18 | -26.2% | Mar 31, 2023 |
| J.P. Morgan | Analyst unavailable | $267 | $218.26 | -5.3% | Dec 16, 2022 |
| UBS | Analyst unavailable | $226 | $220.94 | -19.8% | Dec 15, 2022 |
| Morgan Stanley | Analyst unavailable | $242 | $219.35 | -14.1% | Dec 2, 2022 |
| Truist Financial | Analyst unavailable | $247 | $214.57 | -12.4% | Nov 30, 2022 |
| Scotiabank | Nicholas Yulico | $211 | $210.46 | -25.1% | Nov 29, 2022 |
| Goldman Sachs | Analyst unavailable | $252 | $210.47 | -10.6% | Nov 14, 2022 |
| Truist Financial | Analyst unavailable | $324 | $286.83 | +15.0% | Aug 22, 2022 |
| Mizuho Securities | Analyst unavailable | $273 | $261.75 | -3.1% | Jun 27, 2022 |
| Truist Financial | Analyst unavailable | $299 | $259.44 | +6.1% | Jun 24, 2022 |
| Stifel Nicolaus | Analyst unavailable | $352 | $277.36 | +24.9% | Jun 9, 2022 |
| Truist Financial | Analyst unavailable | $323 | $279.9 | +14.6% | May 25, 2022 |
| RBC Capital | Analyst unavailable | $375 | $339.77 | +33.0% | Apr 28, 2022 |
| KeyBanc | Jordan Sadler | $371 | $345.64 | +31.6% | Jan 13, 2022 |
| Scotiabank | Nicholas Yulico | $338 | $338.03 | +19.9% | Dec 16, 2021 |
| Citigroup | Nicholas Joseph | $370 | $348.22 | +31.3% | Dec 13, 2021 |
| Stifel Nicolaus | Simon Yarmak | $390 | $340.79 | +38.4% | Dec 7, 2021 |
| J.P. Morgan | Anthony Paolone | $363 | $338.24 | +28.8% | Dec 6, 2021 |
| Wells Fargo | Tammi Fique | $345 | $340.97 | +22.4% | Nov 22, 2021 |
| Evercore ISI | Steve Sakwa | $381 | $330.83 | +35.2% | Oct 25, 2021 |
| Goldman Sachs | Chandni Luthra | $325 | $324.77 | +15.3% | Sep 23, 2021 |
| Piper Sandler | Alexander Goldfarb | $390 | $330.07 | +38.4% | Sep 1, 2021 |
Track every rating change on ESS the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session close
Stock move
-1.1%
Event window
SPY move
-0.0%
Same window
Abnormal move
-1.1%
Stock minus SPY
Volume
2.4×
Versus trailing sessions
Subsequent drift
+4.3%
Up to 20 sessions
ESSSPY benchmark
Follow ESS with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
From Q4 2025 to Q1 2026, Essex's bullish score improved from 78 to 82, reflecting stronger execution on occupancy and capital deployment. Key developments include: (1) an early $90 million redemption of structured-finance securities pulled forward from 2027/28, creating a near-term FFO headwind; (2) a $62 million share buyback at $243.76 per share (6.5% implied FFO yield) that offset the redemption impact; (3) cap-rate compression of 50 bps on West Coast assets since 2024, with Essex deploying $1.7 billion as the largest buyer; and (4) a 20-bp YoY occupancy gain with rent growth led by Northern California. Management also flagged a modest slowdown in Seattle and Los Angeles, and expense growth that is timing-related and expected to normalize in H2.
Guidance delta
Full-year 2026 guidance was maintained. The early structured-finance redemption headwind was offset by aggressive share repurchases, resulting in no change to the full-year outlook. Management expressed confidence in continued rent-growth momentum through the peak leasing season. Controllable expense growth is projected at approximately 2% for the year, with H2 expense timing expected to normalize after a flat Q1.
Key takeaways
- Core FFO per share of $1.65 exceeded the midpoint of guidance, driven by higher same-property revenue and flat operating expenses.
- Occupancy-focused strategy produced a 20-bp YoY occupancy gain and strong rent growth, especially in Northern California.
- Early structured-finance redemptions ($90M pulled forward from 2027/28) and a $62M share buyback at $243.76 offset each other, keeping full-year guidance unchanged.
- Cap rates remain in the mid-4% range, offering a discount to private market valuations and supporting continued capital deployment as the largest West Coast buyer.
- Expense growth is timing-related and expected to normalize in H2, with controllable expense growth projected around 2% for the year.
Management priorities
- Maintain occupancy-focused leasing strategy through peak season.
- Pursue selective land acquisitions and ADU development for higher risk-adjusted returns.
- Continue opportunistic share repurchases when pricing is attractive.
- Evaluate disposition opportunities and redeploy proceeds to higher-return assets.
- Monitor cap-rate trends and remain active in the West Coast transaction market.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-31T04:41:49.048448+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-31T04:41:49.045611+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.